Table of Content

1 Metabotropic Glutamate Receptor 5 Market Overview
1.1 Metabotropic Glutamate Receptor 5 Product Scope
1.2 Metabotropic Glutamate Receptor 5 Segment by Type
1.2.1 Global Metabotropic Glutamate Receptor 5 Sales by Type (2016 & 2021 & 2027)
1.2.2 Alloswitch-1
1.2.3 BMS-952048
1.2.4 BMS-955829
1.2.5 Dipraglurant ER
1.2.6 Others
1.3 Metabotropic Glutamate Receptor 5 Segment by Application
1.3.1 Global Metabotropic Glutamate Receptor 5 Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Major Depressive Disorder
1.3.3 Alcohol Addiction
1.3.4 Alzheimer's Disease
1.3.5 Others
1.4 Metabotropic Glutamate Receptor 5 Market Estimates and Forecasts (2016-2027)
1.4.1 Global Metabotropic Glutamate Receptor 5 Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Metabotropic Glutamate Receptor 5 Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Metabotropic Glutamate Receptor 5 Price Trends (2016-2027)

2 Metabotropic Glutamate Receptor 5 Estimates and Forecasts by Region
2.1 Global Metabotropic Glutamate Receptor 5 Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Metabotropic Glutamate Receptor 5 Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Metabotropic Glutamate Receptor 5 Sales Market Share by Region (2016-2021)
2.2.2 Global Metabotropic Glutamate Receptor 5 Revenue Market Share by Region (2016-2021)
2.3 Global Metabotropic Glutamate Receptor 5 Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Metabotropic Glutamate Receptor 5 Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Metabotropic Glutamate Receptor 5 Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Metabotropic Glutamate Receptor 5 Estimates and Projections (2016-2027)
2.4.2 Europe Metabotropic Glutamate Receptor 5 Estimates and Projections (2016-2027)
2.4.3 China Metabotropic Glutamate Receptor 5 Estimates and Projections (2016-2027)
2.4.4 Japan Metabotropic Glutamate Receptor 5 Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Metabotropic Glutamate Receptor 5 Estimates and Projections (2016-2027)
2.4.6 India Metabotropic Glutamate Receptor 5 Estimates and Projections (2016-2027)

3 Global Metabotropic Glutamate Receptor 5 Competition Landscape by Players
3.1 Global Top Metabotropic Glutamate Receptor 5 Players by Sales (2016-2021)
3.2 Global Top Metabotropic Glutamate Receptor 5 Players by Revenue (2016-2021)
3.3 Global Metabotropic Glutamate Receptor 5 Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Metabotropic Glutamate Receptor 5 as of 2020)
3.4 Global Metabotropic Glutamate Receptor 5 Average Price by Company (2016-2021)
3.5 Manufacturers Metabotropic Glutamate Receptor 5 Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Global Metabotropic Glutamate Receptor 5 Market Size by Type
4.1 Global Metabotropic Glutamate Receptor 5 Historic Market Review by Type (2016-2021)
4.1.1 Global Metabotropic Glutamate Receptor 5 Sales Market Share by Type (2016-2021)
4.1.2 Global Metabotropic Glutamate Receptor 5 Revenue Market Share by Type (2016-2021)
4.1.3 Global Metabotropic Glutamate Receptor 5 Price by Type (2016-2021)
4.2 Global Metabotropic Glutamate Receptor 5 Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Metabotropic Glutamate Receptor 5 Sales Forecast by Type (2022-2027)
4.2.2 Global Metabotropic Glutamate Receptor 5 Revenue Forecast by Type (2022-2027)
4.2.3 Global Metabotropic Glutamate Receptor 5 Price Forecast by Type (2022-2027)

5 Global Metabotropic Glutamate Receptor 5 Market Size by Application
5.1 Global Metabotropic Glutamate Receptor 5 Historic Market Review by Application (2016-2021)
5.1.1 Global Metabotropic Glutamate Receptor 5 Sales Market Share by Application (2016-2021)
5.1.2 Global Metabotropic Glutamate Receptor 5 Revenue Market Share by Application (2016-2021)
5.1.3 Global Metabotropic Glutamate Receptor 5 Price by Application (2016-2021)
5.2 Global Metabotropic Glutamate Receptor 5 Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Metabotropic Glutamate Receptor 5 Sales Forecast by Application (2022-2027)
5.2.2 Global Metabotropic Glutamate Receptor 5 Revenue Forecast by Application (2022-2027)
5.2.3 Global Metabotropic Glutamate Receptor 5 Price Forecast by Application (2022-2027)

6 North America Metabotropic Glutamate Receptor 5 Market Facts & Figures
6.1 North America Metabotropic Glutamate Receptor 5 Sales by Company
6.1.1 North America Metabotropic Glutamate Receptor 5 Sales by Company (2016-2021)
6.1.2 North America Metabotropic Glutamate Receptor 5 Revenue by Company (2016-2021)
6.2 North America Metabotropic Glutamate Receptor 5 Sales Breakdown by Type
6.2.1 North America Metabotropic Glutamate Receptor 5 Sales Breakdown by Type (2016-2021)
6.2.2 North America Metabotropic Glutamate Receptor 5 Sales Breakdown by Type (2022-2027)
6.3 North America Metabotropic Glutamate Receptor 5 Sales Breakdown by Application
6.3.1 North America Metabotropic Glutamate Receptor 5 Sales Breakdown by Application (2016-2021)
6.3.2 North America Metabotropic Glutamate Receptor 5 Sales Breakdown by Application (2022-2027)

7 Europe Metabotropic Glutamate Receptor 5 Market Facts & Figures
7.1 Europe Metabotropic Glutamate Receptor 5 Sales by Company
7.1.1 Europe Metabotropic Glutamate Receptor 5 Sales by Company (2016-2021)
7.1.2 Europe Metabotropic Glutamate Receptor 5 Revenue by Company (2016-2021)
7.2 Europe Metabotropic Glutamate Receptor 5 Sales Breakdown by Type
7.2.1 Europe Metabotropic Glutamate Receptor 5 Sales Breakdown by Type (2016-2021)
7.2.2 Europe Metabotropic Glutamate Receptor 5 Sales Breakdown by Type (2022-2027)
7.3 Europe Metabotropic Glutamate Receptor 5 Sales Breakdown by Application
7.3.1 Europe 125 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 125 Sales Breakdown by Application (2022-2027)

8 China Metabotropic Glutamate Receptor 5 Market Facts & Figures
8.1 China Metabotropic Glutamate Receptor 5 Sales by Company
8.1.1 China Metabotropic Glutamate Receptor 5 Sales by Company (2016-2021)
8.1.2 China Metabotropic Glutamate Receptor 5 Revenue by Company (2016-2021)
8.2 China Metabotropic Glutamate Receptor 5 Sales Breakdown by Type
8.2.1 China Metabotropic Glutamate Receptor 5 Sales Breakdown by Type (2016-2021)
8.2.2 China Metabotropic Glutamate Receptor 5 Sales Breakdown by Type (2022-2027)
8.3 China Metabotropic Glutamate Receptor 5 Sales Breakdown by Application
8.3.1 China 153 Sales Breakdown by Application (2016-2021)
8.3.2 China 153 Sales Breakdown by Application (2022-2027)

9 Japan Metabotropic Glutamate Receptor 5 Market Facts & Figures
9.1 Japan Metabotropic Glutamate Receptor 5 Sales by Company
9.1.1 Japan Metabotropic Glutamate Receptor 5 Sales by Company (2016-2021)
9.1.2 Japan Metabotropic Glutamate Receptor 5 Revenue by Company (2016-2021)
9.2 Japan Metabotropic Glutamate Receptor 5 Sales Breakdown by Type
9.2.1 Japan Metabotropic Glutamate Receptor 5 Sales Breakdown by Type (2016-2021)
9.2.2 Japan Metabotropic Glutamate Receptor 5 Sales Breakdown by Type (2022-2027)
9.3 Japan Metabotropic Glutamate Receptor 5 Sales Breakdown by Application
9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Metabotropic Glutamate Receptor 5 Market Facts & Figures
10.1 Southeast Asia Metabotropic Glutamate Receptor 5 Sales by Company
10.1.1 Southeast Asia Metabotropic Glutamate Receptor 5 Sales by Company (2016-2021)
10.1.2 Southeast Asia Metabotropic Glutamate Receptor 5 Revenue by Company (2016-2021)
10.2 Southeast Asia Metabotropic Glutamate Receptor 5 Sales Breakdown by Type
10.2.1 Southeast Asia Metabotropic Glutamate Receptor 5 Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Metabotropic Glutamate Receptor 5 Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Metabotropic Glutamate Receptor 5 Sales Breakdown by Application
10.3.1 Southeast Asia K Pcs Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K Pcs Sales Breakdown by Application (2022-2027)

11 India Metabotropic Glutamate Receptor 5 Market Facts & Figures
11.1 India Metabotropic Glutamate Receptor 5 Sales by Company
11.1.1 India Metabotropic Glutamate Receptor 5 Sales by Company (2016-2021)
11.1.2 India Metabotropic Glutamate Receptor 5 Revenue by Company (2016-2021)
11.2 India Metabotropic Glutamate Receptor 5 Sales Breakdown by Type
11.2.1 India Metabotropic Glutamate Receptor 5 Sales Breakdown by Type (2016-2021)
11.2.2 India Metabotropic Glutamate Receptor 5 Sales Breakdown by Type (2022-2027)
11.3 India Metabotropic Glutamate Receptor 5 Sales Breakdown by Application
11.3.1 India Metabotropic Glutamate Receptor 5 Sales Breakdown by Application (2016-2021)
11.3.2 India Metabotropic Glutamate Receptor 5 Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Metabotropic Glutamate Receptor 5 Business
12.1 Addex Therapeutics Ltd
12.1.1 Addex Therapeutics Ltd Corporation Information
12.1.2 Addex Therapeutics Ltd Business Overview
12.1.3 Addex Therapeutics Ltd Metabotropic Glutamate Receptor 5 Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Addex Therapeutics Ltd Metabotropic Glutamate Receptor 5 Products Offered
12.1.5 Addex Therapeutics Ltd Recent Development
12.2 Aevi Genomic Medicine Inc
12.2.1 Aevi Genomic Medicine Inc Corporation Information
12.2.2 Aevi Genomic Medicine Inc Business Overview
12.2.3 Aevi Genomic Medicine Inc Metabotropic Glutamate Receptor 5 Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Aevi Genomic Medicine Inc Metabotropic Glutamate Receptor 5 Products Offered
12.2.5 Aevi Genomic Medicine Inc Recent Development
12.3 Bristol-Myers Squibb Company
12.3.1 Bristol-Myers Squibb Company Corporation Information
12.3.2 Bristol-Myers Squibb Company Business Overview
12.3.3 Bristol-Myers Squibb Company Metabotropic Glutamate Receptor 5 Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Bristol-Myers Squibb Company Metabotropic Glutamate Receptor 5 Products Offered
12.3.5 Bristol-Myers Squibb Company Recent Development
12.4 Eisai Co Ltd
12.4.1 Eisai Co Ltd Corporation Information
12.4.2 Eisai Co Ltd Business Overview
12.4.3 Eisai Co Ltd Metabotropic Glutamate Receptor 5 Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Eisai Co Ltd Metabotropic Glutamate Receptor 5 Products Offered
12.4.5 Eisai Co Ltd Recent Development
12.5 Eli Lilly and Company
12.5.1 Eli Lilly and Company Corporation Information
12.5.2 Eli Lilly and Company Business Overview
12.5.3 Eli Lilly and Company Metabotropic Glutamate Receptor 5 Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Eli Lilly and Company Metabotropic Glutamate Receptor 5 Products Offered
12.5.5 Eli Lilly and Company Recent Development
12.6 Heptares Therapeutics Ltd
12.6.1 Heptares Therapeutics Ltd Corporation Information
12.6.2 Heptares Therapeutics Ltd Business Overview
12.6.3 Heptares Therapeutics Ltd Metabotropic Glutamate Receptor 5 Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Heptares Therapeutics Ltd Metabotropic Glutamate Receptor 5 Products Offered
12.6.5 Heptares Therapeutics Ltd Recent Development
12.7 Johnson & Johnson
12.7.1 Johnson & Johnson Corporation Information
12.7.2 Johnson & Johnson Business Overview
12.7.3 Johnson & Johnson Metabotropic Glutamate Receptor 5 Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Johnson & Johnson Metabotropic Glutamate Receptor 5 Products Offered
12.7.5 Johnson & Johnson Recent Development
12.8 Merz Pharma GmbH & Co KgaA
12.8.1 Merz Pharma GmbH & Co KgaA Corporation Information
12.8.2 Merz Pharma GmbH & Co KgaA Business Overview
12.8.3 Merz Pharma GmbH & Co KgaA Metabotropic Glutamate Receptor 5 Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Merz Pharma GmbH & Co KgaA Metabotropic Glutamate Receptor 5 Products Offered
12.8.5 Merz Pharma GmbH & Co KgaA Recent Development
12.9 Novartis AG
12.9.1 Novartis AG Corporation Information
12.9.2 Novartis AG Business Overview
12.9.3 Novartis AG Metabotropic Glutamate Receptor 5 Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Novartis AG Metabotropic Glutamate Receptor 5 Products Offered
12.9.5 Novartis AG Recent Development
12.10 Richter Gedeon Nyrt
12.10.1 Richter Gedeon Nyrt Corporation Information
12.10.2 Richter Gedeon Nyrt Business Overview
12.10.3 Richter Gedeon Nyrt Metabotropic Glutamate Receptor 5 Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Richter Gedeon Nyrt Metabotropic Glutamate Receptor 5 Products Offered
12.10.5 Richter Gedeon Nyrt Recent Development
12.11 Sumitomo Dainippon Pharma Co Ltd
12.11.1 Sumitomo Dainippon Pharma Co Ltd Corporation Information
12.11.2 Sumitomo Dainippon Pharma Co Ltd Business Overview
12.11.3 Sumitomo Dainippon Pharma Co Ltd Metabotropic Glutamate Receptor 5 Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Sumitomo Dainippon Pharma Co Ltd Metabotropic Glutamate Receptor 5 Products Offered
12.11.5 Sumitomo Dainippon Pharma Co Ltd Recent Development
12.12 Toray Industries Inc
12.12.1 Toray Industries Inc Corporation Information
12.12.2 Toray Industries Inc Business Overview
12.12.3 Toray Industries Inc Metabotropic Glutamate Receptor 5 Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Toray Industries Inc Metabotropic Glutamate Receptor 5 Products Offered
12.12.5 Toray Industries Inc Recent Development

13 Metabotropic Glutamate Receptor 5 Manufacturing Cost Analysis
13.1 Metabotropic Glutamate Receptor 5 Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Metabotropic Glutamate Receptor 5
13.4 Metabotropic Glutamate Receptor 5 Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Metabotropic Glutamate Receptor 5 Distributors List
14.3 Metabotropic Glutamate Receptor 5 Customers

15 Market Dynamics
15.1 Metabotropic Glutamate Receptor 5 Market Trends
15.2 Metabotropic Glutamate Receptor 5 Drivers
15.3 Metabotropic Glutamate Receptor 5 Market Challenges
15.4 Metabotropic Glutamate Receptor 5 Market Restraints

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Metabotropic Glutamate Receptor 5 Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Metabotropic Glutamate Receptor 5 Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Metabotropic Glutamate Receptor 5 Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Metabotropic Glutamate Receptor 5 Sales (K Pcs) by Region (2016-2021)
Table 5. Global Metabotropic Glutamate Receptor 5 Sales Market Share by Region (2016-2021)
Table 6. Global Metabotropic Glutamate Receptor 5 Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Metabotropic Glutamate Receptor 5 Revenue Share by Region (2016-2021)
Table 8. Global Metabotropic Glutamate Receptor 5 Sales (K Pcs) Forecast by Region (2022-2027)
Table 9. Global Metabotropic Glutamate Receptor 5 Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Metabotropic Glutamate Receptor 5 Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Metabotropic Glutamate Receptor 5 Revenue Share Forecast by Region (2022-2027)
Table 12. Global Metabotropic Glutamate Receptor 5 Sales (K Pcs) of Key Companies (2016-2021)
Table 13. Global Metabotropic Glutamate Receptor 5 Sales Share by Company (2016-2021)
Table 14. Global Metabotropic Glutamate Receptor 5 Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Metabotropic Glutamate Receptor 5 Revenue Share by Company (2016-2021)
Table 16. Global Metabotropic Glutamate Receptor 5 by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Metabotropic Glutamate Receptor 5 as of 2020)
Table 17. Global Metabotropic Glutamate Receptor 5 Average Price (USD/Pcs) of Key Company (2016-2021)
Table 18. Manufacturers Metabotropic Glutamate Receptor 5 Manufacturing Sites and Area Served
Table 19. Manufacturers Metabotropic Glutamate Receptor 5 Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Metabotropic Glutamate Receptor 5 Sales (K Pcs) by Type (2016-2021)
Table 22. Global Metabotropic Glutamate Receptor 5 Sales Share by Type (2016-2021)
Table 23. Global Metabotropic Glutamate Receptor 5 Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Metabotropic Glutamate Receptor 5 Price (USD/Pcs) by Type (2016-2021)
Table 25. Global Metabotropic Glutamate Receptor 5 Sales Share by Type (2022-2027)
Table 26. Global Metabotropic Glutamate Receptor 5 Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Metabotropic Glutamate Receptor 5 Revenue Share by Type (2022-2027)
Table 28. Global Metabotropic Glutamate Receptor 5 Price (USD/Pcs) by Type (2022-2027)
Table 29. Global Metabotropic Glutamate Receptor 5 Sales (K Pcs) by Application (2016-2021)
Table 30. Global Metabotropic Glutamate Receptor 5 Sales Share by Application (2016-2021)
Table 31. Global Metabotropic Glutamate Receptor 5 Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Metabotropic Glutamate Receptor 5 Price (USD/Pcs) by Application (2016-2021)
Table 33. Global Metabotropic Glutamate Receptor 5 Sales (K Pcs) by Application (2022-2027)
Table 34. Global Metabotropic Glutamate Receptor 5 Sales Share by Application (2022-2027)
Table 35. Global Metabotropic Glutamate Receptor 5 Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Metabotropic Glutamate Receptor 5 Revenue Share by Application (2022-2027)
Table 37. Global Metabotropic Glutamate Receptor 5 Price (USD/Pcs) by Application (2022-2027)
Table 38. North America Metabotropic Glutamate Receptor 5 Sales (K Pcs) by Company (2016-2021)
Table 39. North America Metabotropic Glutamate Receptor 5 Sales Market Share by Company (2016-2021)
Table 40. North America Metabotropic Glutamate Receptor 5 Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Metabotropic Glutamate Receptor 5 Revenue Market Share by Company (2016-2021)
Table 42. North America Metabotropic Glutamate Receptor 5 Sales by Type (2016-2021) & (K Pcs)
Table 43. North America Metabotropic Glutamate Receptor 5 Sales Market Share by Type (2016-2021)
Table 44. North America Metabotropic Glutamate Receptor 5 Sales by Type (2022-2027) & (K Pcs)
Table 45. North America Metabotropic Glutamate Receptor 5 Sales Market Share by Type (2022-2027)
Table 46. North America Metabotropic Glutamate Receptor 5 Sales by Application (2016-2021) & (K Pcs)
Table 47. North America Metabotropic Glutamate Receptor 5 Sales Market Share by Application (2016-2021)
Table 48. North America Metabotropic Glutamate Receptor 5 Sales by Application (2022-2027) & (K Pcs)
Table 49. North America Metabotropic Glutamate Receptor 5 Sales Market Share by Application (2022-2027)
Table 50. Europe Metabotropic Glutamate Receptor 5 Sales (K Pcs) by Company (2016-2021)
Table 51. Europe Metabotropic Glutamate Receptor 5 Sales Market Share by Company (2016-2021)
Table 52. Europe Metabotropic Glutamate Receptor 5 Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Metabotropic Glutamate Receptor 5 Revenue Market Share by Company (2016-2021)
Table 54. Europe Metabotropic Glutamate Receptor 5 Sales by Type (2016-2021) & (K Pcs)
Table 55. Europe Metabotropic Glutamate Receptor 5 Sales Market Share by Type (2016-2021)
Table 56. Europe Metabotropic Glutamate Receptor 5 Sales by Type (2022-2027) & (K Pcs)
Table 57. Europe Metabotropic Glutamate Receptor 5 Sales Market Share by Type (2022-2027)
Table 58. Europe Metabotropic Glutamate Receptor 5 Sales by Application (2016-2021) & (K Pcs)
Table 59. Europe Metabotropic Glutamate Receptor 5 Sales Market Share by Application (2016-2021)
Table 60. Europe Metabotropic Glutamate Receptor 5 Sales by Application (2022-2027) & (K Pcs)
Table 61. Europe Metabotropic Glutamate Receptor 5 Sales Market Share by Application (2022-2027)
Table 62. China Metabotropic Glutamate Receptor 5 Sales (K Pcs) by Company (2016-2021)
Table 63. China Metabotropic Glutamate Receptor 5 Sales Market Share by Company (2016-2021)
Table 64. China Metabotropic Glutamate Receptor 5 Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Metabotropic Glutamate Receptor 5 Revenue Market Share by Company (2016-2021)
Table 66. China Metabotropic Glutamate Receptor 5 Sales by Type (2016-2021) & (K Pcs)
Table 67. China Metabotropic Glutamate Receptor 5 Sales Market Share by Type (2016-2021)
Table 68. China Metabotropic Glutamate Receptor 5 Sales by Type (2022-2027) & (K Pcs)
Table 69. China Metabotropic Glutamate Receptor 5 Sales Market Share by Type (2022-2027)
Table 70. China Metabotropic Glutamate Receptor 5 Sales by Application (2016-2021) & (K Pcs)
Table 71. China Metabotropic Glutamate Receptor 5 Sales Market Share by Application (2016-2021)
Table 72. China Metabotropic Glutamate Receptor 5 Sales by Application (2022-2027) & (K Pcs)
Table 73. China Metabotropic Glutamate Receptor 5 Sales Market Share by Application (2022-2027)
Table 74. Japan Metabotropic Glutamate Receptor 5 Sales (K Pcs) by Company (2016-2021)
Table 75. Japan Metabotropic Glutamate Receptor 5 Sales Market Share by Company (2016-2021)
Table 76. Japan Metabotropic Glutamate Receptor 5 Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Metabotropic Glutamate Receptor 5 Revenue Market Share by Company (2016-2021)
Table 78. Japan Metabotropic Glutamate Receptor 5 Sales by Type (2016-2021) & (K Pcs)
Table 79. Japan Metabotropic Glutamate Receptor 5 Sales Market Share by Type (2016-2021)
Table 80. Japan Metabotropic Glutamate Receptor 5 Sales by Type (2022-2027) & (K Pcs)
Table 81. Japan Metabotropic Glutamate Receptor 5 Sales Market Share by Type (2022-2027)
Table 82. Japan Metabotropic Glutamate Receptor 5 Sales by Application (2016-2021) & (K Pcs)
Table 83. Japan Metabotropic Glutamate Receptor 5 Sales Market Share by Application (2016-2021)
Table 84. Japan Metabotropic Glutamate Receptor 5 Sales by Application (2022-2027) & (K Pcs)
Table 85. Japan Metabotropic Glutamate Receptor 5 Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Metabotropic Glutamate Receptor 5 Sales (K Pcs) by Company (2016-2021)
Table 87. Southeast Asia Metabotropic Glutamate Receptor 5 Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Metabotropic Glutamate Receptor 5 Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Metabotropic Glutamate Receptor 5 Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Metabotropic Glutamate Receptor 5 Sales by Type (2016-2021) & (K Pcs)
Table 91. Southeast Asia Metabotropic Glutamate Receptor 5 Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Metabotropic Glutamate Receptor 5 Sales by Type (2022-2027) & (K Pcs)
Table 93. Southeast Asia Metabotropic Glutamate Receptor 5 Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Metabotropic Glutamate Receptor 5 Sales by Application (2016-2021) & (K Pcs)
Table 95. Southeast Asia Metabotropic Glutamate Receptor 5 Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Metabotropic Glutamate Receptor 5 Sales by Application (2022-2027) & (K Pcs)
Table 97. Southeast Asia Metabotropic Glutamate Receptor 5 Sales Market Share by Application (2022-2027)
Table 98. India Metabotropic Glutamate Receptor 5 Sales (K Pcs) by Company (2016-2021)
Table 99. India Metabotropic Glutamate Receptor 5 Sales Market Share by Company (2016-2021)
Table 100. India Metabotropic Glutamate Receptor 5 Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Metabotropic Glutamate Receptor 5 Revenue Market Share by Company (2016-2021)
Table 102. India Metabotropic Glutamate Receptor 5 Sales by Type (2016-2021) & (K Pcs)
Table 103. India Metabotropic Glutamate Receptor 5 Sales Market Share by Type (2016-2021)
Table 104. India Metabotropic Glutamate Receptor 5 Sales by Type (2022-2027) & (K Pcs)
Table 105. India Metabotropic Glutamate Receptor 5 Sales Market Share by Type (2022-2027)
Table 106. India Metabotropic Glutamate Receptor 5 Sales by Application (2016-2021) & (K Pcs)
Table 107. India Metabotropic Glutamate Receptor 5 Sales Market Share by Application (2016-2021)
Table 108. India Metabotropic Glutamate Receptor 5 Sales by Application (2022-2027) & (K Pcs)
Table 109. India Metabotropic Glutamate Receptor 5 Sales Market Share by Application (2022-2027)
Table 110. Addex Therapeutics Ltd Corporation Information
Table 111. Addex Therapeutics Ltd Description and Business Overview
Table 112. Addex Therapeutics Ltd Metabotropic Glutamate Receptor 5 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 113. Addex Therapeutics Ltd Metabotropic Glutamate Receptor 5 Product
Table 114. Addex Therapeutics Ltd Recent Development
Table 115. Aevi Genomic Medicine Inc Corporation Information
Table 116. Aevi Genomic Medicine Inc Description and Business Overview
Table 117. Aevi Genomic Medicine Inc Metabotropic Glutamate Receptor 5 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 118. Aevi Genomic Medicine Inc Metabotropic Glutamate Receptor 5 Product
Table 119. Aevi Genomic Medicine Inc Recent Development
Table 120. Bristol-Myers Squibb Company Corporation Information
Table 121. Bristol-Myers Squibb Company Description and Business Overview
Table 122. Bristol-Myers Squibb Company Metabotropic Glutamate Receptor 5 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 123. Bristol-Myers Squibb Company Metabotropic Glutamate Receptor 5 Product
Table 124. Bristol-Myers Squibb Company Recent Development
Table 125. Eisai Co Ltd Corporation Information
Table 126. Eisai Co Ltd Description and Business Overview
Table 127. Eisai Co Ltd Metabotropic Glutamate Receptor 5 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 128. Eisai Co Ltd Metabotropic Glutamate Receptor 5 Product
Table 129. Eisai Co Ltd Recent Development
Table 130. Eli Lilly and Company Corporation Information
Table 131. Eli Lilly and Company Description and Business Overview
Table 132. Eli Lilly and Company Metabotropic Glutamate Receptor 5 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 133. Eli Lilly and Company Metabotropic Glutamate Receptor 5 Product
Table 134. Eli Lilly and Company Recent Development
Table 135. Heptares Therapeutics Ltd Corporation Information
Table 136. Heptares Therapeutics Ltd Description and Business Overview
Table 137. Heptares Therapeutics Ltd Metabotropic Glutamate Receptor 5 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 138. Heptares Therapeutics Ltd Metabotropic Glutamate Receptor 5 Product
Table 139. Heptares Therapeutics Ltd Recent Development
Table 140. Johnson & Johnson Corporation Information
Table 141. Johnson & Johnson Description and Business Overview
Table 142. Johnson & Johnson Metabotropic Glutamate Receptor 5 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 143. Johnson & Johnson Metabotropic Glutamate Receptor 5 Product
Table 144. Johnson & Johnson Recent Development
Table 145. Merz Pharma GmbH & Co KgaA Corporation Information
Table 146. Merz Pharma GmbH & Co KgaA Metabotropic Glutamate Receptor 5 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 147. Merz Pharma GmbH & Co KgaA Description and Business Overview
Table 148. Merz Pharma GmbH & Co KgaA Metabotropic Glutamate Receptor 5 Product
Table 149. Merz Pharma GmbH & Co KgaA Recent Development
Table 150. Novartis AG Corporation Information
Table 151. Novartis AG Metabotropic Glutamate Receptor 5 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 152. Novartis AG Description and Business Overview
Table 153. Novartis AG Metabotropic Glutamate Receptor 5 Product
Table 154. Novartis AG Recent Development
Table 155. Richter Gedeon Nyrt Corporation Information
Table 156. Richter Gedeon Nyrt Description and Business Overview
Table 157. Richter Gedeon Nyrt Metabotropic Glutamate Receptor 5 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 158. Richter Gedeon Nyrt Metabotropic Glutamate Receptor 5 Product
Table 159. Richter Gedeon Nyrt Recent Development
Table 160. Sumitomo Dainippon Pharma Co Ltd Corporation Information
Table 161. Sumitomo Dainippon Pharma Co Ltd Description and Business Overview
Table 162. Sumitomo Dainippon Pharma Co Ltd Metabotropic Glutamate Receptor 5 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 163. Sumitomo Dainippon Pharma Co Ltd Metabotropic Glutamate Receptor 5 Product
Table 164. Sumitomo Dainippon Pharma Co Ltd Recent Development
Table 165. Toray Industries Inc Corporation Information
Table 166. Toray Industries Inc Description and Business Overview
Table 167. Toray Industries Inc Metabotropic Glutamate Receptor 5 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 168. Toray Industries Inc Metabotropic Glutamate Receptor 5 Product
Table 169. Toray Industries Inc Recent Development
Table 170. Production Base and Market Concentration Rate of Raw Material
Table 171. Key Suppliers of Raw Materials
Table 172. Metabotropic Glutamate Receptor 5 Distributors List
Table 173. Metabotropic Glutamate Receptor 5 Customers List
Table 174. Metabotropic Glutamate Receptor 5 Market Trends
Table 175. Metabotropic Glutamate Receptor 5 Market Drivers
Table 176. Metabotropic Glutamate Receptor 5 Market Challenges
Table 177. Metabotropic Glutamate Receptor 5 Market Restraints
Table 178. Research Programs/Design for This Report
Table 179. Key Data Information from Secondary Sources
Table 180. Key Data Information from Primary Sources
List of Figures
Figure 1. Metabotropic Glutamate Receptor 5 Product Picture
Figure 2. Global Metabotropic Glutamate Receptor 5 Sales Market Share by Type in 2021 & 2027
Figure 3. Alloswitch-1 Product Picture
Figure 4. BMS-952048 Product Picture
Figure 5. BMS-955829 Product Picture
Figure 6. Dipraglurant ER Product Picture
Figure 7. Others Product Picture
Figure 8. Global Metabotropic Glutamate Receptor 5 Sales Market Share by Application in 2021 & 2027
Figure 9. Major Depressive Disorder Examples
Figure 10. Alcohol Addiction Examples
Figure 11. Alzheimer's Disease Examples
Figure 12. Others Examples
Figure 13. Global Metabotropic Glutamate Receptor 5 Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Metabotropic Glutamate Receptor 5 Sales Growth Rate (2016-2027) & (US$ Million)
Figure 15. Global Metabotropic Glutamate Receptor 5 Sales (K Pcs) Growth Rate (2016-2027)
Figure 16. Global Metabotropic Glutamate Receptor 5 Price Trends Growth Rate (2016-2027) (USD/Pcs)
Figure 17. Global Metabotropic Glutamate Receptor 5 Revenue Market Share by Region: 2016 VS 2021
Figure 18. Global Metabotropic Glutamate Receptor 5 Revenue Market Share by Region: 2021 VS 2027
Figure 19. North America Metabotropic Glutamate Receptor 5 Revenue (Million USD) Growth Rate (2016-2027)
Figure 20. North America Metabotropic Glutamate Receptor 5 Sales (K Pcs) Growth Rate (2016-2027)
Figure 21. Europe Metabotropic Glutamate Receptor 5 Revenue (Million USD) Growth Rate (2016-2027)
Figure 22. Europe Metabotropic Glutamate Receptor 5 Sales (Million USD) Growth Rate (2016-2027)
Figure 23. China Metabotropic Glutamate Receptor 5 Revenue (Million USD) Growth Rate (2016-2027)
Figure 24. China Metabotropic Glutamate Receptor 5 Sales (Million USD) and Growth Rate (2016-2027)
Figure 25. Japan Metabotropic Glutamate Receptor 5 Revenue (Million USD) Growth Rate (2016-2027)
Figure 26. Japan Metabotropic Glutamate Receptor 5 Sales (Million USD) Growth Rate (2016-2027)
Figure 27. Southeast Asia Metabotropic Glutamate Receptor 5 Revenue (Million USD) Growth Rate (2016-2027)
Figure 28. Southeast Asia Metabotropic Glutamate Receptor 5 Sales (Million USD) Growth Rate (2016-2027)
Figure 29. India Metabotropic Glutamate Receptor 5 Revenue (Million USD) Growth Rate (2016-2027)
Figure 30. India Metabotropic Glutamate Receptor 5 Sales (Million USD) Growth Rate (2016-2027)
Figure 31. Global 5 Largest Metabotropic Glutamate Receptor 5 Players Market Share by Revenue in Metabotropic Glutamate Receptor 5: 2016 & 2020
Figure 32. Metabotropic Glutamate Receptor 5 Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 33. Global Metabotropic Glutamate Receptor 5 Revenue Share by Type (2016-2021)
Figure 34. Global Metabotropic Glutamate Receptor 5 Revenue Growth Rate by Type in 2016 & 2020
Figure 35. Global Metabotropic Glutamate Receptor 5 Revenue Share by Application (2016-2021)
Figure 36. Global Metabotropic Glutamate Receptor 5 Revenue Growth Rate by Application in 2016 & 2020
Figure 37. North America Metabotropic Glutamate Receptor 5 Sales Market Share by Type in 2020
Figure 38. North America Metabotropic Glutamate Receptor 5 Sales Market Share by Application in 2020
Figure 39. Europe Metabotropic Glutamate Receptor 5 Sales Market Share by Type in 2020
Figure 40. Europe Metabotropic Glutamate Receptor 5 Sales Market Share by Application in 2020
Figure 41. China Metabotropic Glutamate Receptor 5 Sales Market Share by Type in 2020
Figure 42. China Metabotropic Glutamate Receptor 5 Sales Market Share by Application in 2020
Figure 43. Japan Metabotropic Glutamate Receptor 5 Sales Market Share by Type in 2020
Figure 44. Japan Metabotropic Glutamate Receptor 5 Sales Market Share by Application in 2020
Figure 45. Southeast Asia Metabotropic Glutamate Receptor 5 Sales Market Share by Type in 2020
Figure 46. Southeast Asia Metabotropic Glutamate Receptor 5 Sales Market Share by Application in 2020
Figure 47. India Metabotropic Glutamate Receptor 5 Sales Market Share by Type in 2020
Figure 48. India Metabotropic Glutamate Receptor 5 Sales Market Share by Application in 2020
Figure 49. Key Raw Materials Price Trend
Figure 50. Manufacturing Cost Structure of Metabotropic Glutamate Receptor 5
Figure 51. Manufacturing Process Analysis of Metabotropic Glutamate Receptor 5
Figure 52. Metabotropic Glutamate Receptor 5 Industrial Chain Analysis
Figure 53. Channels of Distribution
Figure 54. Distributors Profiles
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed